Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00522145
Status:
COMPLETED
Last Update Posted:
2022-05-13
First Post:
2007-08-27
Brief Title:
Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib
Sponsor:
Kadmon Corporation LLC
Organization:
Kadmon Corporation LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-05
Start Date Type:
None
Primary Completion Date:
2009-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-27
First Submit QC Date:
August 27 2007
Study First Post Date:
2007-08-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2012-01-24
Disp First Submit QC Date:
January 24 2012
Disp First Post Date:
2012-01-30
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2022-05-09
Last Update Post Date:
2022-05-13
Last Update Post Date Type:
ACTUAL